Luminescences of the 2023 Bethesda System for Reporting Thyroid Cytopathology, 3rd edition, in Thyroidology

Abstract

Mater artium necessitas. The Bethesda System for Reporting Thyroid Cytopathology (TBSRCT), per se, has still been crucial for Endocrine Pathologists, Endocrine Surgeons, Neck-Endocrine Surgeons, Endocrinologists, Head&Neck Surgeons, Laryngologists, Head&Neck Radiologists, Nuclear Medicine, and Thyroidologists, globally. The 2010 TBSRTC, 1st edition, was initially proposed in Bethesda, Maryland, USA, in 2007, providing Thyroidologists to utilize a standardized reporting system for thyroid fine-needle aspiration (FNA) [1]. The 2015 American Thyroid Association management guidelines have also endorsed wielding TBSRTC [2] through this delicate papillon endocrine gland [5-9]. Furthermore, a special 2½-hour symposium was moderated by Ali and Vielh at the 19th International Congress of Cytology, ICC, in Pacifico Yokohama, Japan on 28 May–01 June 2016 [10-12]. Subsequently, the 2017 TBSRTC, 2nd edition, was then published by amendment of indeterminate cytology [13].

Keywords

• Thyroid gland
• Thyroid nodule
• Ultrasonography
• Subcategorization
• Subdivision
• Bethesda
• Endocrine Pathology
• Endocrine Surgery
• Thyroidology
• Thyroidologists.